PTEN Germline Mutations in Patients Initially Tested for Other Hereditary Cancer Syndromes: Would Use of Risk Assessment Tools Reduce Genetic Testing?
Authors:
- 13 September 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 18 (10) , 1083-1090
Abstract
Learning Objectives: Cite the risk assessment tools available for several hereditary cancer predisposition syndromes. Describe ways in which use of these risk assessment tools can lead to cost savings and decreased time to correct diagnosis. Explain the impact of correct genetic diagnosis on the patient's medical management and on predictive testing for family members.Keywords
Funding Information
- NIH (P01CA124570)
- National Cancer Institute
- William Randolph Hearst Foundations, Healthnet Foundation
This publication has 23 references indexed in Scilit:
- Lifetime Cancer Risks in Individuals with GermlinePTENMutationsClinical Cancer Research, 2012
- Frequency of Germline PTEN Mutations in Differentiated Thyroid CancerThyroid®, 2011
- The PREMM1,2,6 Model Predicts Risk of MLH1, MSH2, and MSH6 Germline Mutations Based on Cancer HistoryGastroenterology, 2011
- A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 ProbandsThe American Journal of Human Genetics, 2011
- Frequent Gastrointestinal Polyps and Colorectal Adenocarcinomas in a Prospective Series of PTEN Mutation CarriersGastroenterology, 2010
- Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancerBreast Cancer Research and Treatment, 2010
- Cancer phenomics: RET and PTEN as illustrative modelsNature Reviews Cancer, 2006
- Prediction of Germline Mutations and Cancer Risk in the Lynch SyndromeJAMA, 2006
- Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome: Table 1Journal of Medical Genetics, 2004
- The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)Diseases of the Colon & Rectum, 1991